Global At-Home Cancer Testing Kits Market Report – Segmented by Sample Type (Blood, Urine, or Saliva); By Distribution Channel (Retail Pharmacies, Online Pharmacies, Direct-to-Consumer Platforms); and Region - Size, Share, Growth Analysis | Forecast (2024 – 2030)
Published: 2024 - January
Report Code: IM-15275
Format:
Region: Global
Chapter 1. At-Home Cancer Testing Kits Market – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2. At-Home Cancer Testing Kits Market – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 - 2030
2.3.2. Impact on Supply – Demand
Chapter 3. At-Home Cancer Testing Kits Market – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4. At-Home Cancer Testing Kits Market - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. At-Home Cancer Testing Kits Market - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6. At-Home Cancer Testing Kits Market - By Sample Type
6.1 Blood
6.2 Urine
6.3 Saliva
Chapter 7. At-Home Cancer Testing Kits Market - By Distribution Channel
7.1 Retail pharmacies
7.2 Online pharmacies
7.3 Direct-to-consumer Platforms
Chapter 8. At-Home Cancer Testing Kits Market - By Region
8.1 North America
8.2 Europe
8.3 Asia-Pacific
8.4 Latin America
8.5 The Middle East
8.6 Africa
Chapter 9. At-Home Cancer Testing Kits Market - Key Players
9.1 Lepu Medical Technology Co., Ltd.
9.2 ulti med Products GmbH
9.3 Laboratory Corporation of America Holdings
9.4 ELITech Group SAS
9.5 GY Highland Biotech LLC
9.6 Exact Sciences Corp.
9.7 Everlywell, Inc.
9.8 Abingdon Health Quidel Corporation
9.9 Pinnacle Biolabs
9.10 iDNA
Download Sample
Choose License Type
2850
5250
4500
1800
Frequently Asked Questions
At-home cancer testing kits are diagnostic tools people may use in their homes to conduct quick tests and receive immediate results. They aid in the early, more curable stage of cancer detection and screening, sometimes even before a person exhibits any symptoms.
The Global At-Home Cancer Testing Kits Market was estimated to be worth USD 6.2 billion in 2022 and is projected to reach a value of USD 9.23 billion by 2030, growing at a CAGR of 5.1% during the forecast period 2023-2030.
Convenience, cost, and timeliness of these goods are further market factors for at-home cancer testing kits and through at-home cancer testing kits, early diagnosis of cancer is essential for successful treatment and better patient outcomes
Lepu Medical Technology Co., Ltd., ulti med Products GmbH, Laboratory Corporation of America Holdings, ELITech Group SAS, GY Highland Biotech LLC, Exact Sciences Corp., Everlywell, Inc., Abingdon Health Quidel Corporation, Pinnacle Biolabs, iDNA these are some key players.
At-Home Cancer Testing Kits' market revenue growth is mostly constrained by the high cost of diagnostic kits
